CASE PRESENTATIONS {#s1}
==================

Index case (II-1, [Supplemental Fig. 1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a003301/-/DC1)) is a 15-yr-old male with intellectual disability (ID), severe speech impairment, acquired microcephaly, and hypotonia ([Table 1](#MCS003301OKUTB1){ref-type="table"}). The pregnancy was unremarkable except for elevated α-fetoprotein (AFP) levels on maternal serum screening, which were later found normal in amniotic fluid analysis. He was born at 31 wk of gestation with normal weight (1.47 kg \[25%--50%\]), length (40.6 cm \[50%\]), and head circumference (28 cm \[25%--50%\]). He was admitted to the neonatal intensive care unit (NICU) because of prematurity and spent 45 d in the hospital with no major complications. He was noted to have neonatal tooth eruption. At 3 mo of age he was severely hypotonic. He had a transient mild elevation of his liver enzymes without an identifiable etiology during infancy, which resolved spontaneously. He sat without support at 4 yr of age, started crawling at ∼4.5 yr of age, and now can walk with a gait trainer but usually scoots around on his bottom. He is nonverbal. He has had no regression of his milestones nor has he had problems with weight gain or short stature, but his head circumference fell \>2 SDs below the mean at ∼18 mo of age, and he remained microcephalic afterward. He has no problems with feeding and sleeping. He has repetitive movements and rocks his legs back and forth when seated and kicks his legs repeatedly when sitting on the floor. There is no history of seizures and an overnight ambulatory EEG at age 4--5 yr showed no epileptiform discharges. A brain MRI was also found normal. Previous genetic studies including karyotype, chromosomal microarray, fragile X, MECP2 sequencing, and metabolic screening (urine organic acids, very long chain fatty acids, and lysosomal storage disorders) were all normal.

###### 

Clinical findings of patients with biallelic variants in *VARS*

  ---------------------------------------------------------------------------------------------------------------------------------------------------
                                           This study       Karaca et al. 2015   [@MCS003301OKUC6]                                 
  ---------------------------------------- ---------------- -------------------- ------------------- -------------- -------------- ------------------
  Patient ID                               II-1             II-2                 BAB3643             BAB3186        BAB3187        II-2

  Gender                                   Male             Male                 Female              Female         Female         Male

  Age                                      15-yr-old        10-yr-old            ?                   ?              ?              32-mo-old

  Genotype                                 p.Ala22Asp\      p.Ala22Asp\          p.Arg1058Gln\       p.Leu885Phe\   p.Leu885Phe\   c.1577-2A\>G\
                                           p.Phe1072Leu     p.Phe1072Leu         p.Arg1058Gln        p.Leu885Phe    p.Leu885Phe    p.Met1064Ile

  Intellectual disability                  Yes              Yes                  Yes                 Yes            Yes            Yes

  Speech                                   Nonverbal        Nonverbal            NA                  NA             NA             Nonverbal

  Microcephaly (congenital vs. acquired)   Yes (acquired)   Yes (NA)             Yes (NA)            Yes (NA)       Yes (NA)       Yes (congenital)

  Seizures                                 No               No                   Yes                 Yes            Yes            Yes

  Hypotonia                                Yes              Yes                  NA                  NA             NA             Yes

  Cortical atrophy                         No               NA                   Yes                 Yes            Yes            Yes

  Other                                                                                                                            

  Prematurity                              Yes              Yes                  NA                  NA             NA             No

  Elevated liver enzymes                   Yes              Yes                  NA                  NA             NA             No

  Stereotypic behavior                     Yes              No                   NA                  NA             NA             No

  Neonatal tooth                           Yes              No                   NA                  NA             NA             No

  Volvulus                                 No               Yes                  NA                  NA             NA             No

  Dysmorphic features                      Yes              No                   NA                  NA             NA             No
  ---------------------------------------------------------------------------------------------------------------------------------------------------

NA, not available.

Case 2 (II-2, [Supplemental Fig. 1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a003301/-/DC1)) is the 10-yr-old brother of the proband, who is similarly affected with ID, severe speech impairment, microcephaly, hypotonia, transient elevation of liver enzymes in infancy, and prematurity. He was born at 27 wk of gestation with intestinal volvulus which was repaired surgically in the first week of life. He has always been underweight, and his normalized height has just recently started to decline. He is also nonverbal and nonambulatory.

There is no history of consanguinity between parents and the remaining family history is unremarkable. The parents are both of European ethnicity.

VARIANT INTERPRETATION {#s2}
======================

Our patients are compound heterozygous for one novel and one ultra-rare missense variant, NM_006295:c.65C\>A:p.Ala22Asp and NM_006295:c.3214T\>C:p.Phe1072Leu, in the gene encoding cytoplasmic valyl-tRNA synthetase protein (*VARS*). Although the p.Ala22Asp variant is not present in any population databases, p.Phe1072Leu is observed in one NonFinnish European allele in gnomAD. Computational prediction algorithms favor pathogenicity for both variants. Variants are evaluated as of uncertain significance (VUS) according to American College of Medical Genetics and Genomics (ACMG) variant interpretation guidelines fulfilling PM3_Supporting, PP1, and PP4 criteria ([@MCS003301OKUC5]), although because of the overlapping clinical features to the previously reported cases they are likely causative of the patients' phenotypes ([Table 2](#MCS003301OKUTB2){ref-type="table"}). No other likely pathogenic variants were identified that segregated with the phenotype in the family.

###### 

Genomic findings and variant interpretation

  -----------------------------------------------------------------------------------------------------------------------------------
  Gene     Genomic location         HGVS cDNA    HGVS protein   Zygosity       Parent of origin   Variant interpretation
  -------- ------------------------ ------------ -------------- -------------- ------------------ -----------------------------------
  *VARS*   Chr 6:31762930 (hg19)\   c.65C\>A     p.Ala22Asp     Heterozygous   Maternal           Variant of uncertain significance
           Chr 6:31795153 (hg38)                                                                  

  *VARS*   Chr 6:31747459 (hg19)\   c.3214T\>C   p.Phe1072Leu   Heterozygous   Paternal           Variant of uncertain significance
           Chr 6:31779682 (hg38)                                                                  
  -----------------------------------------------------------------------------------------------------------------------------------

Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. There are 37 aminoacyl-tRNA synthetases (18 cytoplasmic, 17 mitochondrial, 2 bifunctional) in human cells, and biallelic variants in many aminoacyl-tRNA synthetases have been reported in individuals with neurodevelopmental disorders ([@MCS003301OKUC4]). Variants in *VARS* were first identified in patients with microcephaly, ID, and cortical atrophy ([@MCS003301OKUC2]), and a recent study reported additional variants in patients with similar clinical findings associated with biallelic variants in *VARS* ([Table 1](#MCS003301OKUTB1){ref-type="table"}; [@MCS003301OKUC6]). VARS has three important conserved domains: glutathione S-transferase, carboxy-terminal domain (GST_C), tRNA synthetases class I (tRNA_synt_1), and anticodon-binding domain of tRNA (Anticodon_1). Four predicted likely pathogenic variants reported in the literature and in ClinVar are missense variants, and they all are located in either tRNA_synt_1 or Anticodon_1 domain. The only reported variant that is located outside of those domains is a canonical splice site variant ([Fig. 1](#MCS003301OKUF1){ref-type="fig"}). The p.Phe1072Leu variant is also located in the Anticodon_1 domain (SIFT: Damaging; PolyPhen-2: Benign; CADD v1.3: 24.8). The p.Ala22Asp variant is not located in any of the domains, but the prediction scores for this variant are supportive of pathogenicity (SIFT: Damaging; Polyphen-2: Damaging; CADD v1.3: 32). All of the previously reported variants and the variants we report are located in highly conserved residues ([Fig. 1](#MCS003301OKUF1){ref-type="fig"}).

![Distribution of reported *VARS* variants in the literature and ClinVar over 2D representation of VARS domains given on InterPro for P26640 (SYVC_HUMAN) and the mutated residues' sequence alignment across species. Mutated residues are shown in bold black font for previously reported variants and in bold red font for variants reported in our study. HUMAN (P26640); *Homo sapiens*, PANTR (H2QSM5); *Pan troglodytes* (chimpanzee), MACMU (G7MRK4); *Rhesus macaque*; MOUSE (G3UY93); *Mus musculus*; CANLF (E2RTJ7), *Canis lupus familiaris* (dog); LOXAF (G5E7F5), African elephant; RAT (Q04462), *Rattus norvegicus*. ^†^This variant is deposited into ClinVar but not reported in any publication.](MCS003301Oku_F1){#MCS003301OKUF1}

SUMMARY {#s4}
=======

Here we report biallelic missense variants in *VARS* in two similarly affected siblings with ID, severe speech impairment, acquired microcephaly, hypotonia, prematurity, and transient elevation of liver enzymes in infancy, consistent with previously reported findings in patients with biallelic *VARS* variants. Our patients did not have seizures or cortical atrophy, and this is different from some other reported patients in the literature, expanding the phenotypic spectrum of NDMSCA. Our patients share overlapping clinical features reported in other autosomal recessively inherited aminoacyl-tRNA synthetase disorders (i.e., IARS; MIM \#617093, LARS; MIM \#615438) including elevated liver enzymes along with microcephaly and hypotonia. Future clinical and functional studies are needed to better define the genotype--phenotype correlations and assess molecular mechanism of disease.

METHODS {#s3}
=======

Clinical exome sequencing was performed with peripheral blood DNA samples from the two affected brothers and their mother and was nondiagnostic. Raw data was requested from the diagnostic laboratory and reanalysis was performed. Variants were filtered by their population allele frequencies in Exome Aggregation Consortium (ExAC) ([@MCS003301OKUC3]), Exome Sequencing Project (ESP; <http://evs.gs.washington.edu/EVS/>), 1000 Genomes Samples ([@MCS003301OKUC1]), and Genome Aggregation Database (gnomAD) ([@MCS003301OKUC3]) using 1% and 3% thresholds for autosomal dominant and autosomal recessive inheritance models, respectively. Biallelic predicted pathogenic variants that fit to an autosomal recessive inheritance pattern were identified. Variants were confirmed by Sanger sequencing, and they segregated with the affected individuals in the family ([Supplemental Fig. 1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a003301/-/DC1)).

ADDITIONAL INFORMATION {#s5}
======================

Data Deposition and Access {#s5a}
--------------------------

All sequence data and interpreted variants have been deposited in ClinVar (<https://www.ncbi.nlm.nih.gov/clinvar/>) under accession numbers SCV000803173 (for c.65C\>A) and SCV000803174 (for c.3214T\>C).
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